Nanoscope in the News
-
Retina Today: AAV Gene Therapy Trials to Watch
August 3, 2021 by Wilson PJ
-
BIO.org: The Pandemic Highlights Need for More Women Scientists
July 28, 2021 by Wilson PJ
-
Modern Retina: Optogenetic Gene Trial Begins, First Patient Dosed
July 28, 2021 by Wilson PJ
-
Ophthalmology Times: First patient dosed in optogenetic gene therapy trial
July 19, 2021 by Nanoscope Therapeutics
-
Fighting Blindness Foundation: Nanoscope Therapeutics Launches Phase 2b Clinical Trial for Optogenetic Therapy
July 19, 2021 by Nanoscope Therapeutics
-
Fort Worth Inc.: Bedford’s Nanoscope Begins Human Trial of Drug for Retinitis Pigmentosa
July 19, 2021 by Nanoscope Therapeutics
-
BioSpace: Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b Clinical Trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with RP
June 24, 2021 by Nanoscope Therapeutics
-
Ft. Worth Business Press: Nanoscope Therapeutics cleared to open Phase 2b clinical trial for vision therapy
June 23, 2021 by Nanoscope Therapeutics
-
Dallas Morning News: Bedford biotech’s eyesight-restoring gene therapy received FDA approval to test in the U.S.
June 23, 2021 by Nanoscope Therapeutics
-
Dallas Innovates: Bedford Biotech Restores “Meaningful Vision” in Blind Patients With Gene Therapy—and May Soon Go Public
June 22, 2021 by Nanoscope Therapeutics
-
Forbes: What is ‘Optogenetics’? Behind the Technology That’s Bringing Sight to The Blind.
June 16, 2021 by Nanoscope Therapeutics
-
Fort Worth Business: North Texas biotechnology company shows vision improvement via gene therapy
June 4, 2021 by Nanoscope Therapeutics
-
Dallas Morning News: Bedford Biotech’s Gene Therapy Improves Sight for 11 Patients with Rare Genetic Retinal Disorder
June 4, 2021 by Nanoscope Therapeutics
-
Citybiz: Nanoscope’s Optogenetic Gene Therapy Restores Clinically Meaningful Vision in 11 Patients Blinded by Retinitis Pigmentosa
June 3, 2021 by Nanoscope Therapeutics
-
Opthalmology Times: Optogenetic gene therapy restores vision in 11 RP patients
June 3, 2021 by Nanoscope Therapeutics
-
Ocular Surgery News: Optogenetics, goggles increase visual perception in case of inherited retinal dystrophy
June 3, 2021 by Nanoscope Therapeutics
-
Nature Gene Therapy: Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice
May 19, 2021 by Nanoscope Therapeutics
-
14 Emerging Tech Trends for 2021—and Dallas-Area Companies That Are Innovating for the Future
March 6, 2021 by Nanoscope Therapeutics
-
Nature: Light-activated genetic therapy to treat blindness enters clinic
February 9, 2021 by Nanoscope Therapeutics
-
Injection that could improve fading sight in aging eyes starts human trials after curing blindness in mice
October 22, 2020 by Nanoscope Therapeutics
